Association of fluvoxamine with mortality and symptom resolution among inpatients with COVID-19
Gespeichert in:
| Veröffentlicht in: | Molecular psychiatry 2024-12, Vol.29 (12), p.3938-3939 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 3939 |
|---|---|
| container_issue | 12 |
| container_start_page | 3938 |
| container_title | Molecular psychiatry |
| container_volume | 29 |
| creator | Zeng, Guangting Li, Jianqiang Wang, Linlin Zhang, Zanling |
| description | |
| doi_str_mv | 10.1038/s41380-024-02635-0 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3071085857</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3134574844</sourcerecordid><originalsourceid>FETCH-LOGICAL-c256t-367b826407b55a2123a44b797728056b118e9ab4b5bbc239788d1008a310de883</originalsourceid><addsrcrecordid>eNp9kE9PwyAYh4nROJ1-AQ-miRcv1ZcChR6X-W-JiRf1SqBls6aFCa26by9bpyYePBBI3uf3e8mD0AmGCwxEXAaKiYAUMhpPTlgKO-gAU56njHGxG9-EFSnFgo7QYQivAOsh20cjIgrggIsDJCchuLJWXe1s4ubJvOnf3adqa2uSj7p7SVrnO9XU3SpRtkrCql12rk28Ca7pNyHVOrtIaruMHcZ2YYhNH55nVykujtDeXDXBHG_vMXq6uX6c3qX3D7ez6eQ-LTOWdynJuRZZToFrxlSGM6Io1bzgPBPAco2xMIXSVDOty4wUXIgKAwhFMFRGCDJG50Pv0ru33oROtnUoTdMoa1wfJAGOQTDBeETP_qCvrvc2_k4STCjjVFAaqWygSu9C8GYul75ulV9JDHKtXw76ZdQvN_olxNDptrrXral-It--I0AGIMSRXRj_u_uf2i8kVY62</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3134574844</pqid></control><display><type>article</type><title>Association of fluvoxamine with mortality and symptom resolution among inpatients with COVID-19</title><source>Alma/SFX Local Collection</source><creator>Zeng, Guangting ; Li, Jianqiang ; Wang, Linlin ; Zhang, Zanling</creator><creatorcontrib>Zeng, Guangting ; Li, Jianqiang ; Wang, Linlin ; Zhang, Zanling</creatorcontrib><identifier>ISSN: 1359-4184</identifier><identifier>ISSN: 1476-5578</identifier><identifier>EISSN: 1476-5578</identifier><identifier>DOI: 10.1038/s41380-024-02635-0</identifier><identifier>PMID: 38907019</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>692/699/476/1373 ; 692/699/476/1414 ; Behavioral Sciences ; Biological Psychology ; Correspondence ; COVID-19 ; Fluvoxamine ; Medicine ; Medicine & Public Health ; Neurosciences ; Pharmacotherapy ; Psychiatry</subject><ispartof>Molecular psychiatry, 2024-12, Vol.29 (12), p.3938-3939</ispartof><rights>The Author(s), under exclusive licence to Springer Nature Limited 2024</rights><rights>The Author(s), under exclusive licence to Springer Nature Limited 2024.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c256t-367b826407b55a2123a44b797728056b118e9ab4b5bbc239788d1008a310de883</cites><orcidid>0000-0002-8707-0487</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38907019$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zeng, Guangting</creatorcontrib><creatorcontrib>Li, Jianqiang</creatorcontrib><creatorcontrib>Wang, Linlin</creatorcontrib><creatorcontrib>Zhang, Zanling</creatorcontrib><title>Association of fluvoxamine with mortality and symptom resolution among inpatients with COVID-19</title><title>Molecular psychiatry</title><addtitle>Mol Psychiatry</addtitle><addtitle>Mol Psychiatry</addtitle><subject>692/699/476/1373</subject><subject>692/699/476/1414</subject><subject>Behavioral Sciences</subject><subject>Biological Psychology</subject><subject>Correspondence</subject><subject>COVID-19</subject><subject>Fluvoxamine</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Neurosciences</subject><subject>Pharmacotherapy</subject><subject>Psychiatry</subject><issn>1359-4184</issn><issn>1476-5578</issn><issn>1476-5578</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kE9PwyAYh4nROJ1-AQ-miRcv1ZcChR6X-W-JiRf1SqBls6aFCa26by9bpyYePBBI3uf3e8mD0AmGCwxEXAaKiYAUMhpPTlgKO-gAU56njHGxG9-EFSnFgo7QYQivAOsh20cjIgrggIsDJCchuLJWXe1s4ubJvOnf3adqa2uSj7p7SVrnO9XU3SpRtkrCql12rk28Ca7pNyHVOrtIaruMHcZ2YYhNH55nVykujtDeXDXBHG_vMXq6uX6c3qX3D7ez6eQ-LTOWdynJuRZZToFrxlSGM6Io1bzgPBPAco2xMIXSVDOty4wUXIgKAwhFMFRGCDJG50Pv0ru33oROtnUoTdMoa1wfJAGOQTDBeETP_qCvrvc2_k4STCjjVFAaqWygSu9C8GYul75ulV9JDHKtXw76ZdQvN_olxNDptrrXral-It--I0AGIMSRXRj_u_uf2i8kVY62</recordid><startdate>202412</startdate><enddate>202412</enddate><creator>Zeng, Guangting</creator><creator>Li, Jianqiang</creator><creator>Wang, Linlin</creator><creator>Zhang, Zanling</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-8707-0487</orcidid></search><sort><creationdate>202412</creationdate><title>Association of fluvoxamine with mortality and symptom resolution among inpatients with COVID-19</title><author>Zeng, Guangting ; Li, Jianqiang ; Wang, Linlin ; Zhang, Zanling</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c256t-367b826407b55a2123a44b797728056b118e9ab4b5bbc239788d1008a310de883</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>692/699/476/1373</topic><topic>692/699/476/1414</topic><topic>Behavioral Sciences</topic><topic>Biological Psychology</topic><topic>Correspondence</topic><topic>COVID-19</topic><topic>Fluvoxamine</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Neurosciences</topic><topic>Pharmacotherapy</topic><topic>Psychiatry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zeng, Guangting</creatorcontrib><creatorcontrib>Li, Jianqiang</creatorcontrib><creatorcontrib>Wang, Linlin</creatorcontrib><creatorcontrib>Zhang, Zanling</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Molecular psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zeng, Guangting</au><au>Li, Jianqiang</au><au>Wang, Linlin</au><au>Zhang, Zanling</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Association of fluvoxamine with mortality and symptom resolution among inpatients with COVID-19</atitle><jtitle>Molecular psychiatry</jtitle><stitle>Mol Psychiatry</stitle><addtitle>Mol Psychiatry</addtitle><date>2024-12</date><risdate>2024</risdate><volume>29</volume><issue>12</issue><spage>3938</spage><epage>3939</epage><pages>3938-3939</pages><issn>1359-4184</issn><issn>1476-5578</issn><eissn>1476-5578</eissn><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>38907019</pmid><doi>10.1038/s41380-024-02635-0</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0002-8707-0487</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1359-4184 |
| ispartof | Molecular psychiatry, 2024-12, Vol.29 (12), p.3938-3939 |
| issn | 1359-4184 1476-5578 1476-5578 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_3071085857 |
| source | Alma/SFX Local Collection |
| subjects | 692/699/476/1373 692/699/476/1414 Behavioral Sciences Biological Psychology Correspondence COVID-19 Fluvoxamine Medicine Medicine & Public Health Neurosciences Pharmacotherapy Psychiatry |
| title | Association of fluvoxamine with mortality and symptom resolution among inpatients with COVID-19 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T17%3A20%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Association%20of%20fluvoxamine%20with%20mortality%20and%20symptom%20resolution%20among%20inpatients%20with%20COVID-19&rft.jtitle=Molecular%20psychiatry&rft.au=Zeng,%20Guangting&rft.date=2024-12&rft.volume=29&rft.issue=12&rft.spage=3938&rft.epage=3939&rft.pages=3938-3939&rft.issn=1359-4184&rft.eissn=1476-5578&rft_id=info:doi/10.1038/s41380-024-02635-0&rft_dat=%3Cproquest_cross%3E3134574844%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3134574844&rft_id=info:pmid/38907019&rfr_iscdi=true |